Implanon Discontinuation Rate and It's Associated Factors in Debre Tabor Town, North Central Ethiopia
Science Journal of Clinical Medicine
Volume 8, Issue 2, March 2019, Pages: 6-12
Received: Apr. 24, 2019;
Accepted: May 24, 2019;
Published: Jun. 13, 2019
Views 466 Downloads 68
Awoke Giletew Wondie, Department of Public Health, Debre Tabor University, Debre Tabor, Ethiopia
Family planning could avert a significant number of maternal mortality and contributes to child survival with its focus on women's rights. Generally, a long-acting reversible contraceptive is more effective and cover all the advantage and eliminates the disadvantages of other types of contraceptives. The acceptance and utilization of long-acting reversible contraceptive including implanon were very low in many developing countries including Ethiopia. The purpose of this study was to assess the level of discontinuation and to identify variables influencing Implanon utilization. A cross-sectional design was conducted between January to December 2018 in Debre Tabor town. In the community, a total of 132 women who have been using or discontinuing Implanon during the study period were selected. Face-to-face interviews using a structured questionnaire were conducted for data collection. The data were entered, cleaned and analyzed by a statistical package for social sciences version 20. The data were processed and analyzed by a statistical package for social sciences version 20 using descriptive and analytical statistics including chi-square test that identified the association between some selected independent variables and implanon discontinuation. The overall implanon discontinuation in the year 2018 was 16.7% in Debre Tabor town. The most frequently mentioned reason for implanon discontinuation was health-related issues (31.8%), side effects (27.3%), desire to have more children (22.7%) and method shift (18.2%). Factors associated with Implanon discontinuation were developing side effects, women who have living children and not providing counseling service. Implanon discontinuation among Implanon users in Debre Tabor town during the year 2018 was found to be high and the most frequently mentioned rationale was health-related issues. Health care providers should provide counseling before Implanon insertion.
Awoke Giletew Wondie,
Implanon Discontinuation Rate and It's Associated Factors in Debre Tabor Town, North Central Ethiopia, Science Journal of Clinical Medicine.
Vol. 8, No. 2,
2019, pp. 6-12.
Kassebaum NJ, Bertozzi-Villa A, Coggeshall MS, Shackelford KA, Steiner C, Heuton KR, Gonzalez-Medina D, Barber R, Huynh C, Dicker D, et al: Global, regional, and national levels and causes of maternal mortality during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053): 1775–812.
Abouzahr C, Wardlaw T. Maternal Mortality in 2000: Estimates by WHO, UNICEF & UNFPA: Department of Reproductive health Research World Health Organization, Geneva; 2004 Http:// www. Who. In/whom estimates 2000. pdf.
Awareness and determinants of family planning practice in Jimma, Ethiopia, http://onlinelibrary.wiley.com/doi/10.1111/j.1466-7657.2006.00492.x/full
BMC Public Health. Withdrawal users' experiences of and attitudes to contraceptive methods: a study from the Eastern district of Tehran, Iran, Rahnama; December 22, 2010; 10: 779.
Adeleye O. A. Akoria Z. O Shuaib and Ognoloh. O. D. Barriers and knowledge of Benefits Regarding Family planning method among women Attending Antenatal clinics in Southern Nigerian community. Asian Journal of medical sciences, 2010, 2(4): 190–194.
Biruk T, Assefa H, Georges R. The prevalence of covert use of contraceptive in Nazareth, Adama town. Population studies and Research center, AAU of 2002.
Central Statistical Agency (CSA) [Ethiopia] and ICF. 2016. Ethiopia Demographic and Health Survey 2016. Addis Ababa, Ethiopia, and Rockville, Maryland, USA: CSA and ICF.
David PH, Reichenbach L, Savelieva I, Vartapetova N, Potemkin. Women's reproductive health needs in Russia: what can we learn from an intervention to improve post-abortion care?. American Red Cross National Headquarters, 2025 E Street NW, Washington DC 2006, USA.
Jamal A. Comparison of factors influences utilization of modern contraceptive methods among Rural and Urban women currently using Family Planning Service in South Wollo Zone Amhara National Regional State, 2010 A. A Ethiopia.
Jane T. Bertrand, Karen H, Robert J. Access Quality of care and medical Barriers in family planning programs. International family planning perspectives, 21: 64-69 &76, 1995, accessed at http://www.dictionary.com
Sergent F, et al., Acceptability of the etonogestrel-containing contraceptive implant (Implanon).[French]. J GynecolObstetBiolReprod, 2004. 33: p. 407-15.
ChaovisitsareeSomsak, et al., One Year Study of Implanon on the Adverse Events and Discontinuation. J Med Assoc Thai 2005. 88(33 ): p. 314-317. MastorAsmah, Khaingsi Lay, and Omar sitiZawiah, Users' perspectives on Implanon in Malaysia, a multicultural Asian country. Open Access Journal of Contraception, 2011. 2: p. 79-84.
MastorAsmah, Khaingsi Lay, and Omar sitiZawiah, Users' perspectives on Implanon in Malaysia, a multicultural Asian country. Open Access Journal of Contraception, 2011. 2: p. 79-84.
Mutihir j. t and Nyangod. d., Indications for removal of etonogestrel implant within two years of use in Jos, Nigeria. East African Medical Journal November 2010. 87 p. 11
Mutihir JT and Nyango DD, One-year experience with Implanon sub-dermal implants in Jos, Nigeria. Nigerian Journal of Clinical Practice, March 2010. 13(1): p. 28-31
Lakha F and Glasier AF, Continuation rates of Implanon in the UK: data from an observational study in a clinical setting Contraception 2006. 74(4): p. 287-9.
Mohamed Abdel-RazikMadiha Said, Implanon Use Pattern among Ministry of Health and Population Clients 2008-2012. December 2012, Faculty of Medicine, Cairo University: Cairo.
Mutihir JT and Daru PH, Implanon sub-dermal implants: a 10-month review of acceptability in Jos, North-Central Nigeria. Nigerian Journal of Clinical Practice, 2008. 11(4): p. 320-323.
Affandi B, An integrated analysis of vaginal bleeding patterns in clinical trials of Implanon. Contraception, 1998. 58(6 Suppl): p. 99S-107S.